[1]
Salazar-Onfray, F. 2025. TRIMELVax: A Novel Innate Immune-Engaging Vaccine for Malignant Melanoma Targeting Neutrophil-Driven Antigen Presentation and T-Cell Activation. South East European Journal of Immunology. 8, CITIM (Mar. 2025), 050. DOI:https://doi.org/10.3889/seejim.2025.6113.